Skip to main content

Table 5 Frequency of dizziness by study group adjusted by gender, age, anaemia at inclusion

From: Efficacy and tolerability of a new formulation of artesunate-mefloquine for the treatment of uncomplicated malaria in adult in Senegal: open randomized trial

Dizziness

Day 1

 

Day 2

  

Day 3

 
 

n (%)

aOR** (95%CI)

p value

n (%)

aOR (95%CI)

p value

n (%)

aOR (95%CI)

p value

*Treatment

         

AL (n = 153)

17 (11.1%)

1

 

8 (5.2)

1

 

11 (7.1)

1

 

AM (n = 157)

35 (22.3%)

2.2 (1.1-4.4)

.02

61 (38.8)

12.5 (5.5 – 28.1)

.001

58 (38.1)

10.2 (4.7-22.3)

.001

  1. * AM = Artesunate-mefloquine; AL = Artemether-Lumefantrine.
  2. **aOR: adjusted odds ratio. The analysis of the association between dizziness and treatment was adjusted by mean haemoglobin at inclusion, age, gender.
Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us